Contineum Therapeutics

J&J-Partnered Contineum Corrals $110M From IPO for Clinical Trials in Fibrosis & MS

Contineum Therapeutics plans to spend most of its IPO cash on clinical testing of a lead drug candidate in development for idiopathic pulmonary fibrosis and multiple sclerosis. This small molecule blocks a competitive target pursued by several other companies, including Bristol Myers Squibb and AbbVie.

By Frank Vinluan

BioPharma, Pharma

With MS & Fibrosis Trials Planned, J&J-Partnered Contineum Now Preps for IPO

Contineum Therapeutics, which emerged from a Verant Ventures startup creation engine, has filed paperwork for an IPO. The biotech’s clinical-stage pipeline spans multiple sclerosis, idiopathic pulmonary fibrosis, and depression.

By Frank Vinluan

Simplify Salon & Spa Employee Management with Meevo’s Comprehensive Software

Meevo offers an all-in-one solution for managing salon and spa employees. From scheduling and time tracking to payroll and promotions, Meevo streamlines operations and supports growth.

By Meevo

The Top Appointment Scheduling Software for Wellness Clinics

Scheduling software is helpful for wellness business owners in numerous ways. They get everything they need to create appointments, reschedule clients and track cancellations in one platform.

By PatientNow

These Are the Top-Rated Autism Therapy Centers in Texas

There are a number of criteria for selecting the best autism therapy centers. Parents choosing a facility or professionals seeking to improve their offerings should consider certain standards to ensure the right fit.

By Behavioral Innovations